Charles Julia F, Aliprantis Antonios O
Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Department of Medicine, Division of Rheumatology, Allergy, and Immunology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Trends Mol Med. 2014 Aug;20(8):449-59. doi: 10.1016/j.molmed.2014.06.001. Epub 2014 Jul 6.
As the only cells definitively shown to degrade bone, osteoclasts are key mediators of skeletal diseases including osteoporosis. Bone-forming osteoblasts, and hematopoietic and immune system cells, each influence osteoclast formation and function, but the reciprocal impact of osteoclasts on these cells is less well appreciated. We highlight here the functions that osteoclasts perform beyond bone resorption. First, we consider how osteoclast signals may contribute to bone formation by osteoblasts and to the pathology of bone lesions such as fibrous dysplasia and giant cell tumors. Second, we review the interaction of osteoclasts with the hematopoietic system, including the stem cell niche and adaptive immune cells. Connections between osteoclasts and other cells in the bone microenvironment are discussed within a clinically relevant framework.
作为唯一被明确证明可降解骨骼的细胞,破骨细胞是包括骨质疏松症在内的骨骼疾病的关键介质。成骨的成骨细胞、造血细胞和免疫系统细胞均会影响破骨细胞的形成和功能,但破骨细胞对这些细胞的反向影响却鲜为人知。在此,我们重点介绍破骨细胞在骨吸收之外所发挥的功能。首先,我们探讨破骨细胞信号如何促进成骨细胞的骨形成以及诸如骨纤维异常增殖症和巨细胞瘤等骨病变的病理过程。其次,我们回顾破骨细胞与造血系统的相互作用,包括干细胞龛和适应性免疫细胞。破骨细胞与骨微环境中其他细胞之间的联系将在临床相关框架内进行讨论。